These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 745691)

  • 41. Further studies on the interaction between bromocriptine and SKF38393 in reserpine and alpha methyl-para-tyrosine-treated mice.
    Jackson DM; Ross SB; Hashizume M
    Psychopharmacology (Berl); 1988; 94(3):321-7. PubMed ID: 2895938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of 1,3-dimethyl-5-adamantanamine (D-145) on catecholaminergic neurons of the rat brain, Histofluorescence studies.
    Smialowska M
    Pol J Pharmacol Pharm; 1976; 28(3):259-67. PubMed ID: 951308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological manipulation of gamma-aminobutyric acid (GABA) in morphine analgesia, tolerance and physical dependence.
    Ho IK; Loh HH; Way EL
    Life Sci; 1976 May; 18(10):1111-23. PubMed ID: 945436
    [No Abstract]   [Full Text] [Related]  

  • 44. n-Pentylamine: effect on motor activity of mice.
    Widy-Tyszkiewicz E; Sourkes TL
    Pharmacol Biochem Behav; 1980 Sep; 13(3):385-90. PubMed ID: 6106950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A study of the role of catecholamines in the response to various central stimulants.
    Sayers AC; Handley SL
    Eur J Pharmacol; 1973 Jul; 23(1):47-55. PubMed ID: 4147437
    [No Abstract]   [Full Text] [Related]  

  • 46. Amantadine decreases d-amphetamine stimulation and increases d-amphetamine anorexia in mice.
    Clark R; Smith DH; Vernier VG; Rubin AA
    Proc Soc Exp Biol Med; 1976 Feb; 151(2):434-6. PubMed ID: 1061960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of memantine on the anticonvulsant effects of the antiepileptic drugs.
    Chojnacka-Wójcik E; Tatarczyńska E; Maj J
    Pol J Pharmacol Pharm; 1983; 35(6):511-5. PubMed ID: 6429651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Possible involvement of the central dopaminergic system in the antireserpine effect of LSD.
    Menon MK; Clark WG; Masuoka DT
    Psychopharmacology (Berl); 1977 May; 52(3):291-7. PubMed ID: 406633
    [No Abstract]   [Full Text] [Related]  

  • 49. Locomotion and stereotyped behaviours induced by 1-amino-3,5-dimethyladamantane (D 145) and apomorphine in the rat: a comparison.
    Ljungberg T
    J Pharm Pharmacol; 1986 Jul; 38(7):520-5. PubMed ID: 2875153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suppression of ethanol-induced locomotor stimulation by GABA-like drugs.
    Cott J; Carlsson A; Engel J; Lindqvist M
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 295(3):203-9. PubMed ID: 1012342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of memantine on membrane properties and postsynaptic potentials in neurons of Aplysia californica].
    Klee MR
    Arzneimittelforschung; 1982; 32(10):1259-67. PubMed ID: 6295410
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence for an inhibitory gabergic control of the meso-limbic dopamine neurons: possibility of improving treatment of schizophrenia by combined treatment with neuroleptics and gabergic drugs.
    Fuxe K; Hökfelt T; Ljungdahl A; Agnati L; Johansson O; Perez de la Mora M
    Med Biol; 1975 Jun; 53(3):177-83. PubMed ID: 1160412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological studies on sympathoinhibition produced by the medial medullary depressor region: proposed gamma-aminobutyric acid involvement in inhibition of somatosympathetic reflexes.
    Taylor DG; Taylor KA; Antonaccio MJ
    J Pharmacol Exp Ther; 1982 Sep; 222(3):517-25. PubMed ID: 6286921
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of 1,3-dimethyl-5-aminoadamantane hydrochloride (DMAA) on the stretch-induced reflex tension of flexor muscles and the excitability of the gamma-loop in decerebrate and spinal cats.
    Wand P; Sontag KH; Cremer H
    Arzneimittelforschung; 1977 Jul; 27(7):1477-81. PubMed ID: 578477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The level of GABA in the brain and locomotor behavior.
    Grimm V; Gottesfeld Z; Wassermann I; Samuel D
    Pharmacol Biochem Behav; 1975; 3(4):573-8. PubMed ID: 1103159
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of CNS catecholamine-depleting drugs on dextroamphetamine-induced elevation of halothane MAC.
    Johnston RR; Way WL; Miller RD
    Anesthesiology; 1974 Jul; 41(1):57-61. PubMed ID: 4275974
    [No Abstract]   [Full Text] [Related]  

  • 57. [Interaction of sydnocarb with preparations influencing the metabolism of catecholamines].
    Al'tshuler RA; Roshchina LF; Mashkovskiĭ MD
    Farmakol Toksikol; 1976; 39(1):9-14. PubMed ID: 943326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antagonism of D-amphetamine by alpha-methyl-L-tyrosine: behavioral evidence for the participation of catecholamine stores and synthesis in the amphetamine stimulant response.
    Stolk JM; Rech RH
    Neuropharmacology; 1970 May; 9(3):249-63. PubMed ID: 4393182
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of amantadine on arterial blood pressure in the rat.
    Maj J; Przewlocka B
    Pol J Pharmacol Pharm; 1974; 26(3):341-9. PubMed ID: 4851603
    [No Abstract]   [Full Text] [Related]  

  • 60. Aminoadamantane derivatives.
    Tilley JW; Kramer MJ
    Prog Med Chem; 1981; 18():1-44. PubMed ID: 7045980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.